Stroke continues to strike even during this pandemic period. We will continue to support Health Care Practitioners during these trying times to work towards a better future.
- Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals
- Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery
- ESOC 2020: Abstracts on NeuroAiD
- Embracing World Stroke Day 2020
- The COVID-19 pandemic have inevitably affected healthcare systems worldwide. Moleac stays committed in supporting front liners during this time more than ever.